{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:38:47Z","timestamp":1790995127726,"version":"4.1.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/jcp.0000000000000087","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T06:17:15Z","timestamp":1392272235000},"page":"244-255","source":"Crossref","is-referenced-by-count":125,"title":["Pharmacotherapy for Mood Disorders in Pregnancy"],"prefix":"10.1097","volume":"34","author":[{"given":"Kristina M.","family":"Deligiannidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Byatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene P.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/acps.12042","article-title":"Antidepressant use in pregnancy: a critical review focused on risks and controversies.","volume":"127","author":"Byatt","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"e7085","DOI":"10.1136\/bmj.e7085","article-title":"Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study.","volume":"345","author":"Boden","year":"2012","journal-title":"BMJ"},{"issue":"11","key":"R13-13-20210128","first-page":"967","article-title":"Mood stabilizers in pregnancy: a systematic review.","volume":"44","author":"Galbally","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1517\/14740338.2012.670419","article-title":"Lithium in pregnancy: the need to treat, the duty to ensure safety.","volume":"11","author":"Gentile","year":"2012","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"R20-13-20210128","first-page":"12","article-title":"Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants.","volume":"6","author":"Bies","year":"2003","journal-title":"J Gend Specif Med"},{"issue":"1","key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199550010-00001","article-title":"Gender as a risk factor for adverse events to medications.","volume":"50","author":"Kando","year":"1995","journal-title":"Drugs"},{"issue":"1","key":"R22-13-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0016-5085(89)90758-0","article-title":"Influence of gender and menopause on gastric emptying and motility.","volume":"96","author":"Hutson","year":"1989","journal-title":"Gastroenterology"},{"issue":"1","key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/00365520310000410","article-title":"Gender differences in gut transit shown with a newly developed radiological procedure.","volume":"38","author":"Sadik","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1365-2125.2003.01868.x","article-title":"The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects.","volume":"56","author":"Palovaara","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1528-1167.2005.10105.x","article-title":"Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.","volume":"46","author":"Reimers","year":"2005","journal-title":"Epilepsia"},{"issue":"10","key":"R32-13-20210128","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"R34-13-20210128","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","article-title":"Drug transfer and metabolism by the human placenta.","volume":"43","author":"Syme","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"R39-13-20210128","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1471-0528.2002.01467.x","article-title":"Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta.","volume":"109","author":"Heikkine","year":"2002","journal-title":"BJOG"},{"issue":"1","key":"R42-13-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/jwh.2005.14.19","article-title":"Sex and racial differences in pharmacological response: where is the evidence Pharmacogenetics, pharmacokinetics, and pharmacodynamics.","volume":"14","author":"Anderson","year":"2005","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"R47-13-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1006949816036","article-title":"Metabolism of tricyclic antidepressants.","volume":"19","author":"Rudorfer","year":"1999","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"R50-13-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.1981.tb00929.x","article-title":"Serial changes in renal haemodynamics during normal human pregnancy.","volume":"88","author":"Dunlop","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"issue":"8","key":"R58-13-20210128","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0006-3223(03)00006-4","article-title":"Difficult-to-treat depression: the role of contexts and comorbidities.","volume":"53","author":"Grote","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"1","key":"R60-13-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/mol.56.1.31","article-title":"Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription.","volume":"56","author":"Xie","year":"1999","journal-title":"Mol Pharmacol"},{"issue":"6","key":"R74-13-20210128","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00007691-200412000-00016","article-title":"Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy.","volume":"26","author":"Laine","year":"2004","journal-title":"Ther Drug Monit"},{"issue":"3","key":"R76-13-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00003088-199324030-00003","article-title":"Clinical pharmacokinetics of selective serotonin reuptake inhibitors.","volume":"24","author":"van Harten","year":"1993","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"R93-13-20210128","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-200038060-00001","article-title":"Clinical pharmacokinetics of mirtazapine.","volume":"38","author":"Timmer","year":"2000","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"R99-13-20210128","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1176\/ajp.150.10.1541","article-title":"Tricyclic dose requirements across pregnancy.","volume":"150","author":"Wisner","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"1","key":"R100-13-20210128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004714-199602000-00015","article-title":"Pregnancy and psychotropic medication: changes in blood levels.","volume":"16","author":"Altshuler","year":"1996","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"R102-13-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00023210-200923040-00005","article-title":"Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring.","volume":"23","author":"Grandjean","year":"2009","journal-title":"CNS Drugs"},{"issue":"4","key":"R103-13-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/11586970-000000000-00000","article-title":"Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.","volume":"25","author":"Malhi","year":"2011","journal-title":"CNS Drugs"},{"issue":"3","key":"R105-13-20210128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2007-979199","article-title":"Avoidance of lithium intoxication: advice based on knowledge about the renal lithium clearance under various circumstances.","volume":"32","author":"Thomsen","year":"1999","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"R107-13-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00023210-200923050-00004","article-title":"Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.","volume":"23","author":"Grandjean","year":"2009","journal-title":"CNS Drugs"},{"issue":"2","key":"R110-13-20210128","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.seizure.2007.11.017","article-title":"Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites.","volume":"17","author":"Ohman","year":"2008","journal-title":"Seizure"},{"issue":"3","key":"R112-13-20210128","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eplepsyres.2005.06.004","article-title":"Individual changes in lamotrigine plasma concentrations during pregnancy.","volume":"65","author":"Petrenaite","year":"2005","journal-title":"Epilepsy Res"},{"key":"R115-13-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0074-7742(08)00013-5","article-title":"Antiepileptic drug therapy in pregnancy I: gestation-induced effects on AED pharmacokinetics.","volume":"83","author":"Pennell","year":"2008","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"R116-13-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00003088-200746030-00002","article-title":"Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium.","volume":"46","author":"Tomson","year":"2007","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"R119-13-20210128","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1528-1157.2000.tb00232.x","article-title":"Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation.","volume":"41","author":"Ohman","year":"2000","journal-title":"Epilepsia"},{"issue":"suppl 4","key":"R120-13-20210128","first-page":"3","article-title":"Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications.","volume":"63","author":"Keck","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R126-13-20210128","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1528-1157.1991.tb05253.x","article-title":"Plasma antiepileptic drug concentrations during pregnancy.","volume":"32","author":"Lander","year":"1991","journal-title":"Epilepsia"},{"issue":"3","key":"R127-13-20210128","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0404.1988.tb03646.x","article-title":"The course of epilepsy during pregnancy: a study of 78 cases.","volume":"78","author":"Gjerde","year":"1988","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"R128-13-20210128","first-page":"33","article-title":"Risk factors for the increased seizure frequency during pregnancy and puerperium.","volume":"39","author":"Otani","year":"1985","journal-title":"Folia Psychiatr Neurol Jpn"},{"issue":"5","key":"R131-13-20210128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1600-0404.1985.tb00901.x","article-title":"Concentration of valproate during pregnancy, in the newborn and in breast milk.","volume":"72","author":"Philbert","year":"1985","journal-title":"Acta Neurol Scand"},{"issue":"suppl 1","key":"R132-13-20210128","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1111\/j.1528-1157.1985.tb05724.x","article-title":"Effects of pregnancy on antiepileptic drug utilization.","volume":"26","author":"Levy","year":"1985","journal-title":"Epilepsia"},{"issue":"3A","key":"R135-13-20210128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF01962699","article-title":"Pharmacokinetics of valproate in pregnancy: mother-foetus-newborn.","volume":"14","author":"Johannessen","year":"1992","journal-title":"Pharm Weekbl Sci"},{"issue":"10","key":"R137-13-20210128","first-page":"358","article-title":"The use of lithium during pregnancy and lactation.","volume":"44","author":"Linden","year":"1983","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R138-13-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jmwh.2006.09.002","article-title":"Collaborative management of women with bipolar disorder during pregnancy and postpartum: pharmacologic considerations.","volume":"52","author":"Ward","year":"2007","journal-title":"J Midwifery Womens Health"},{"issue":"1","key":"R140-13-20210128","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1600-0404.2011.01627.x","article-title":"Algorithm for lamotrigine dose adjustment before, during, and after pregnancy.","volume":"126","author":"Sabers","year":"2012","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"R141-13-20210128","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11940-012-0184-7","article-title":"Managing epilepsy during pregnancy: assessing risk and optimizing care.","volume":"14","author":"Krishnamurthy","year":"2012","journal-title":"Curr Treat Options Neurol"},{"issue":"15","key":"R142-13-20210128","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2165\/00003088-200241150-00002","article-title":"Clinical pharmacokinetics of sertraline.","volume":"41","author":"DeVane","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"R143-13-20210128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00007691-200008000-00014","article-title":"Therapeutic drug monitoring of sertraline: variability factors as displayed in a clinical setting.","volume":"22","author":"Lundmark","year":"2000","journal-title":"Ther Drug Monit"},{"key":"R145-13-20210128","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1192\/bjp.150.6.782","article-title":"Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale.","volume":"150","author":"Cox","year":"1987","journal-title":"Br J Psychiatry"},{"issue":"5","key":"R147-13-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1399-5618.2002.01195.x","article-title":"A clinical monitoring form for mood disorders.","volume":"4","author":"Sachs","year":"2002","journal-title":"Bipolar Disord"},{"issue":"6","key":"R149-13-20210128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0447.2009.01490.x","article-title":"A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health.","volume":"121","author":"Warburton","year":"2010","journal-title":"Acta Psychiatr Scand"},{"issue":"10","key":"R152-13-20210128","first-page":"410","article-title":"Lithium treatment during pregnancy, delivery, and lactation: an update.","volume":"51","author":"Schou","year":"1990","journal-title":"J Clin Psychiatry"},{"issue":"5859","key":"R156-13-20210128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bmj.2.5859.137","article-title":"Lithium and pregnancy. II. Hazards to women given lithium during pregnancy and delivery.","volume":"2","author":"Schou","year":"1973","journal-title":"Br Med J"},{"issue":"4","key":"R160-13-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/jwh.2006.15.352","article-title":"A review of postpartum psychosis.","volume":"15","author":"Sit","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"R163-13-20210128","first-page":"89","article-title":"Three cases of delivery under sodium valproateplacental transfer, milk transfer and probable teratogenicity of sodium valproate.","volume":"42","author":"Tsuru","year":"1988","journal-title":"Jpn J Psychiatry Neurol"},{"issue":"10","key":"R164-13-20210128","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/0960327112446516","article-title":"The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study.","volume":"31","author":"Sirmagul","year":"2012","journal-title":"Hum Exp Toxicol"},{"issue":"5","key":"R166-13-20210128","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/FTD.0b013e318261c372","article-title":"Therapeutic drug monitoring in pregnancy.","volume":"34","author":"Matsui","year":"2012","journal-title":"Ther Drug Monit"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0000000000000087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:46:30Z","timestamp":1620942390000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201404000-00013"}},"subtitle":["A Review of Pharmacokinetic Changes and Clinical Recommendations for Therapeutic Drug Monitoring"],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0000000000000087","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}